PerkinElmer aims to expand their reach into the autoimmune and allergy diagnostic market through a $1.3 billion acquisition of EUROIMMUN.
Scientists from the University at Albany (NY, USA) have published their findings on a method that could accurately predict the age of bloodstains at crime scenes for up to 2 years.
Thermo Fisher Scientific Inc. (MA, USA) have announced new technologies that obtain high-resolution separations with increased sensitivity and reproducibility.
Researchers have developed an innovative technique to detect tumor DNA in blood with a greater degree of sensitivity and precision.
OmniComm Systems (FL, USA) has been chosen by a major contract research organization to provide software and services to support clinical research.
Beckman Coulter showcase the Beckman Coulter Diagnostic Difference and a range of new products designed to provide comprehensive solutions for laboratory excellence.
UCL (London, UK) researchers have identified a biomarker for Huntington’s disease that can be measured in blood.
Researchers have developed a nanotechnology platform that could accurately diagnose prostate cancer by using a single drop of blood.
Biosimilar trastuzumab candidate (CT-P6) shown to be similar in efficacy and safety to the reference trastuzumab in data presented at the 2017 American Society of Clinical Oncology Annual Meeting (IN, USA).
New kit promises to reduce costs and improve productivity of insulin bioanalysis workflows across biopharmaceutical research and sports anti-doping industries.